A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire

International Journal of Oncology

Volumn 41, Issue 4, 2012, Pages 1241-1250

  Saucedo Zeni, Nadia ^a   Mewes, Steffi ^a   Niestroj, Robert ^a   Gasiorowski, Lukasz ^b   Murawa, David ^c   Nowaczyk, Piotr ^c   Tomasi, Tatiana ^a   Weber, Ekkehard ^a   Dworacki, Grzegorz ^b   Morgenthaler, Nils G ^a   Jansen, Heike ^d   Propping, Corinna ^d   Sterzynska, Karolina ^b   Dyszkiewicz, Wojciech ^b   Zabel, Maciej ^b   Kiechle, Marion ^d   Reuning, Ute ^d   Schmitt, Manfred ^d   Lücke, Klaus ^a  

^a GILUPI GmbH   (Germany)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c Wielkopolska Cancer Center   (Poland)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Breast cancer; Circulating tumor cells; Epithelial cell adhesion molecule; Medical wire; Non small cell lung cancer

Indexed keywords

CYTOKERATIN; EPITHELIAL CELL ADHESION MOLECULE;

ARTICLE; BIOCOMPATIBILITY; BLOOD; BLOOD VESSEL; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CELL ISOLATION; CELL SURFACE; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; FUNCTIONALIZED STRUCTURED MEDICAL GUIDEWIRE; GUIDE WIRE; HUMAN; HUMAN CELL; IN VIVO CULTURE; LUNG NON SMALL CELL CANCER; MEDICAL DEVICE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION MOLECULES; FEMALE; HEMODYNAMICS; HUMANS; KERATINS; NEOPLASTIC CELLS, CIRCULATING;

EID: 84866509291     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1557     Document Type: Article

References (57)

1. Doroshow JH and Parchment RE: Oncologic phase 0 trials incorporating clinical pharmacodynamics: from concept to patient. Clin Cancer Res 14: 3658-3663, 2008.
2. Kuhlmann J and Wensing G: The applications of biomarkers in early clinical drug development to improve decision-making processes. Curr Clin Pharmacol 1: 185-191, 2006.
3. Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, Stern HM, Yue P, Haverty PM, Bourgon R, Zheng J, Moorhead M, Chaudhuri S, Tomsho LP, Peters BA, Pujara K, Cordes S, Davis DP, Carlton VE, Yuan W, Li L, Wang W, Eigenbrot C, Kaminker JS, Eberhard DA, Waring P, Schuster SC, Modrusan Z, Zhang Z, Stokoe D, De Sauvage FJ, Faham M and Seshagiri S: Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466: 869-873, 2010.
4. Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV, Inserra E, Diederichs S, Lafrate AJ, Bell DW, Digumarthy S, Muzikansky A, Irimia D, Settleman J, Tompkins RG, Lynch TJ, Toner M and Haber DA: Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 359: 366-377, 2008.
5. Dotan E, Cohen SJ, Alpaugh KR and Meropol NJ: Circulating tumor cells: evolving evidence and future challenges. Oncologist 14: 1070-1082, 2009.
6. Krebs MG, Hou JM, Ward TH, Blackhall FH and Dive C: Circulating tumour cells: their utility in cancer management and predicting outcomes. Ther Adv Med Oncol 2: 351-365, 2010.
7. Hou JM, Krebs M, Ward T, Sloane R, Priest L, Hughes A, Clack G, Ranson M, Blackhall F and Dive C: Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol 178: 989-996, 2011.
8. Simpson SJ, Vachula M, Kennedy MJ, Kaizer H, Coon JS, Ghalie R, Williams S and van Epps D: Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry. Exp Hematol 23: 1062-1068, 1995.
9. Ring AE, Zabaglo L, Ormerod MG, Smith IE and Dowsett M: Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques. Br J Cancer 92: 906-912, 2005.
10. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA and Toner M: Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450: 1235-1239, 2007.
11. Bossolasco P, Ricci C, Farina G, Soligo D, Pedretti D, Scanni A and Deliliers GL: Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene. Cancer Detect Prev 26: 60-63, 2002.
12. Iakovlev VV, Goswami RS, Vecchiarelli J, Arneson NC and Done SJ: Quantitative detection of circulating epithelial cells by Q-RT-PCR. Breast Cancer Res Treat 107: 145-154, 2008.
13. Xenidis N, Perraki M, Kafousi M, Apostolaki S, Bolonaki I, Stathopoulou A, Kalbakis K, Androulakis N, Kouroussis C, Pallis T, Christophylakis C, Argyraki K, Lianidou ES, Stathopoulos S, Georgoulias V and Mavroudis D: Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients. J Clin Oncol 24: 3756-3762, 2006.
14. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW and Hayes DF: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351: 781-791, 2004.
15. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LW and Meropol NJ: Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26: 3213-3221, 2008.
16. Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson S, Gornet T, Cristofanilli M and Pantel K: Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 13: 920-928, 2007.
17. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW and Terstappen LW: Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10: 6897-6904, 2004.
18. Tibbe AG, Miller MC and Terstappen LW: Statistical considerations for enumeration of circulating tumor cells. Cytometry A 71: 154-162, 2007.
19. Nedosekin DA, Sarimollaoglu M, Ye JH, Galanzha EI and Zharov VP: In vivo ultra-fast photoacoustic flow cytometry of circulating human melanoma cells using near-infrared high-pulse rate lasers. Cytometry A 79: 825-833, 2011.
20. Barber CJ: Central venous catheter placement for intravenous digital subtraction angiography: an assessment of technical problems and success rate. Br J Radiol 62: 599-602, 1989.
21. Stanton AW, Holroyd B, Northfield JW, Levick JR and Mortimer PS: Forearm blood flow measured by venous occlusion plethysmography in healthy subjects and in women with postmastectomy oedema. Vascular Med 3: 3-8, 1998.
22. Florek E, Brȩborowicz GH, Lücke K, Madejczyk M, Chuchracki M, Dworacki G, Zabel M and Giersig M: The acute systemic toxicity study for normal catheter and cell-select catheter (CSC). Arch Perinatal Med 14: 20-31, 2008.
23. Xu FJ, Li YL, Kang ET and Neoh KG: Heparin-coupled poly(poly(ethylene- glycol) monomethacrylate)-Si(111)) hybrids and their blood compatible surfaces. Biomacromolecules 6: 1759-1768, 2005.
24. Fortune JB and Feustel P: Effect of patient position on size and location of the subclavian vein for percutaneous puncture. Arch Surg 138: 996-1000, 2003.
25. Larson CJ, Moreno JG, Pienta KJ, Gross S, Repollet M, O'Hara SM, Russell T and Terstappen LW: Apoptosis of circulating tumor cells in prostate cancer patients. Cytometry A 62: 46-53, 2004.
26. - objects predict overall survival in castration-resistant prostate cancer. Ann Oncol 21: 1851-1857, 2010.
27. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN and Terstappen LW: Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23: 1420-1430, 2005.
28. Zhe X, Cher ML and Bonfil RD: Circulating tumor cells: finding the needle in the haystack. Am J Cancer Res 1: 740-751, 2011.
29. Steeg PS and Theodorescu D: Metastasis: a therapeutic target for cancer. Nat Clin Pract Oncol 5: 206-219, 2008.
30. Graves H and Czerniecki BJ: Circulating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progression. Patholog Res Int 2011: 621090, 2011.
31. Molloy TJ, Devriese LA, Helgason HH, Bosma AJ, Hauptmann M, Voest EE, Schellens JH and van't Veer LJ: A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer. Br J Cancer 104: 1913-1919, 2011.
32. Li Q, Qi H, Zhou HX, Deng CY, Zhu H, Li JF, Wang XL and Li FR: Detection of micrometastases in peripheral blood of non-small cell lung cancer with a refined immunomagnetic nanoparticle enrichment assay. Int J Nanomed 6: 2175-2181, 2011.
33. O'Flaherty JD, Gray S, Richard D, Fennell D, O'Leary JJ, Blackhall FH and O'Byrne KJ: Circulating tumour cells, their role in metastasis, and their clinical utility in lung cancer. Lung Cancer 76: 19-25, 2012.
34. Sun YF, Yang XR, Zhou J, Qiu SJ, Fan J and Xu Y: Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J Cancer Res Clin Oncol 137: 1151-1173, 2011.
35. Alunni-Fabbroni M and Sandri MT: Circulating tumour cells in clinical practice: methods of detection and possible characterization. Methods 50: 289-297, 2010.
36. Ross JS and Slodkowska EA: Circulating and disseminated tumor cells in the management of breast cancer. Am J Clin Pathol 132: 237-245, 2009.
37. Allan AL and Keeney M: Circulating tumor cell analysis: technical and statistical considerations for application to the clinic. J Oncol 2010: 426218, 2010.
38. Van de Stolpe A, Pantel K, Sleijfer S, Terstappen LW and Den Toonder JM: Circulating tumor cell isolation and diagnostics: toward routine clinical use. Cancer Res 71: 5955-5960, 2011.
39. Sleijfer S, Gratama JW, Sieuwerts AM, Kraan J, Martens JW and Foekens JA: Circulating tumour cell detection on its way to routine diagnostic implementation? Eur J Cancer 43: 2645-2650, 2007.
40. Paterlini-Brechot P and Benali NL: Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 253: 180-204, 2007.
41. Swaby RF and Cristofanilli M: Circulating tumor cells in breast cancer: a tool whose time has come of age. BMC Med 9: 43, 2011.
42. Blümke K, Bilkenroth U, Schmidt U, Melchior A, Füssel S, Bartel F, Heynemann H, Fornara P, Taubert H, Wirth MP and Meye A: Detection of circulating tumor cells from renal carcinoma patients: experiences of a two-center study. Oncol Rep 14: 895-899, 2005.
43. Nichols AC, Lowes LE, Szeto CC, Basmaji J, Dhaliwal S, Chapeskie C, Todorovic B, Read N, Venkatesan V, Hammond A, Palma DA, Winquist E, Ernst S, Fung K, Franklin JH, Yoo J, Koropatnick J, Mymryk JS, Barrett JW and Allan AL: Detection of circulating tumor cells in advanced head and neck cancer using the Cellsearch system. Head Neck doi: 10.1002/hed.21941 [Epub ahead of print] 2011.
44. Lecharpentier A, Vielh P, Perez-Moreno P, Planchard D, Soria JC and Farace F: Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br J Cancer 105: 1338-1341, 2011.
45. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LW and Meropol NJ: Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 20: 1223-1229, 2009.
46. De Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ and Raghavan D: Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 14: 6302-6309, 2008.
47. Poveda A, Kaye SB, McCormack R, Wang S, Parekh T, Ricci D, Lebedinsky CA, Tercero JC, Zintl P and Monk BJ: Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer. Gynecol Oncol 122: 567-572, 2011.
48. Bear HD: Measuring circulating tumor cells as a surrogate end point for adjuvant therapy of breast cancer: what do they mean and what should we do about them? J Clin Oncol 26: 1195-1197, 2008.
49. Pachmann K, Camara O, Kavallaris A, Krauspe S, Malarski N, Gajda M, Kroll T, Jörke C, Hammer U, Altendorf-Hofmann A, Rabenstein C, Pachmann U, Runnebaum I and Höffken K: Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol 26: 1208-1215, 2008.
50. Bidard FC, Mathiot C, Delaloge S, Brain E, Giachetti S, De Cremoux P, Marty M and Pierga JY: Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann Oncol 21: 729-733, 2010.
51. Hofman VJ, Ilie MI, Bonnetaud C, Selva E, Long E, Molina T, Vignaud JM, Fléjou JF, Lantuejoul S, Piaton E, Butori C, Mourad N, Poudenx M, Bahadoran P, Sibon S, Guevara N, Santini J, Vénissac N, Mouroux J, Vielh P and Hofman PM: Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls. Am J Clin Pathol 135: 146-156, 2011.
52. Rolle A, Günzel R, Pachmann U, Willen B, Höffken K and Pachmann K: Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC(R) is a predictor for relapse: a preliminary report. World J Surg Oncol 3: 18, 2005.
53. Fehm T, Solomayer EF, Meng S, Tucker T, Lane N, Wang J and Gebauer G: Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells. Cytotherapy 7: 171-185, 2005.
54. Gascoyne PR, Noshari J, Anderson TJ and Becker FF: Isolation of rare cells from cell mixtures by dielectrophoresis. Electrophoresis 30: 1388-1398, 2009.
55. Mostert B, Kraan J, Sieuwerts AM, van der Spoel P, Bolt-De Vries J, Prager-van der Smissen WJ, Smid M, Timmermans AM, Martens JW, Gratama JW, Foekens JA and Sleijfer S: CD49f-based selection of circulating tumor cells (CTC) improves detection across breast cancer subtypes. Cancer Lett 319: 49-55, 2012.
56. Farace F, Massard C, Vimond N, Drusch F, Jacques N, Billiot F, Laplanche A, Chauchereau A, Lacroix L, Planchard D, Le Moulec S, André F, Fizazi K, Soria JC and Vielh P: A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br J Cancer 105: 847-853, 2011.
57. Flores LM, Kindelberger DW, Ligon AH, Capelletti M, Fiorentino M, Loda M, Cibas ES, Jänne PA and Krop IE: Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer. Br J Cancer 102: 1495-1502, 2010.